ClinicalTrials.Veeva

Menu

Unknown Cause of Acute Liver Failure (HASIPRO)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Liver Failure
Unknown Etiology

Study type

Observational

Funder types

Other

Identifiers

NCT02041637
AOM11030

Details and patient eligibility

About

The purpose of the study is to evaluate the outcome and to determine predictive factors of patients admitted in a context of acute liver failure without identified cause.

Full description

Methodology: Multicentric French national cohort with prospective collection of data and constitution of biobank, in patients hospitalized in a context of acute liver failure without known cause at admission. Follow-up during 3 months for each patients. The primary objective is to determine predictive factors of early mortality. This study is an observational cohort and patients will received standard care during the follow-up.

Enrollment

72 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute liver failure defined by a PT<50% or INR>1.5;
  • with or without hepatic encephalopathy;
  • without cause identified at admission, and non A non B hepatitis;
  • age>18 year old;
  • signed an informed consent.

Exclusion criteria

  • chronic liver disease;
  • Patient under guardianship

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems